Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Benson

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancer|November 1, 1996
Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinomaB B Mittal, M A Zimmer, V Sathiaseelan, et al.
Archives of Internal Medicine|May 1, 1987
Maintenance etidronate in the prevention of malignancy-associated hypercalcemiaJ H Schiller, P Rasmussen, A B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical OncologyC E Desch, A B Benson, T J Smith, et al.
Cancer Research|November 15, 1989
Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapyS C Remick, A B Benson, J L Weese, et al.
Journal of Pain and Symptom Management|March 4, 2000
Management of cancer treatment-related diarrhea. Issues and therapeutic strategiesS Kornblau, A B Benson, R Catalano, et al.
Journal of Surgical Oncology|August 22, 2009
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancerC C Earle, M R Weiser, A Ter Veer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B StudyP J O'Dwyer, J Manola, F H Valone, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinomaL C Scott, J C Yao, A B Benson, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2011
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology GroupH H Yoon, P Catalano, M K Gibson, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Colorectal CancerA B Benson, M A Choti, A M Cohen, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer|November 1, 1996
Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinomaB B Mittal, M A Zimmer, V Sathiaseelan, et al.
Archives of Internal Medicine|May 1, 1987
Maintenance etidronate in the prevention of malignancy-associated hypercalcemiaJ H Schiller, P Rasmussen, A B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical OncologyC E Desch, A B Benson, T J Smith, et al.
Cancer Research|November 15, 1989
Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapyS C Remick, A B Benson, J L Weese, et al.
Journal of Pain and Symptom Management|March 4, 2000
Management of cancer treatment-related diarrhea. Issues and therapeutic strategiesS Kornblau, A B Benson, R Catalano, et al.
Journal of Surgical Oncology|August 22, 2009
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancerC C Earle, M R Weiser, A Ter Veer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B StudyP J O'Dwyer, J Manola, F H Valone, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinomaL C Scott, J C Yao, A B Benson, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2011
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology GroupH H Yoon, P Catalano, M K Gibson, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Colorectal CancerA B Benson, M A Choti, A M Cohen, et al.
Pageof 8